![Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence | Arteriosclerosis, Thrombosis, and Vascular Biology Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/059ec4aa-839a-4ce2-adef-0c265f43ae4a/6ga01.jpeg)
Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence | Arteriosclerosis, Thrombosis, and Vascular Biology
![Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI) | Arteriosclerosis, Thrombosis, and Vascular Biology Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI) | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/5016fdb4-5eb6-465b-9a4c-09af9dc3b1fe/1390ga1.jpg)
Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI) | Arteriosclerosis, Thrombosis, and Vascular Biology
![PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma | Journal of Clinical Pathology PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma | Journal of Clinical Pathology](https://jcp.bmj.com/content/jclinpath/64/10/893/F3.large.jpg)
PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma | Journal of Clinical Pathology
![The PAI‐1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women - SAID - 2012 - Journal of Thrombosis and Haemostasis - Wiley Online Library The PAI‐1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women - SAID - 2012 - Journal of Thrombosis and Haemostasis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/16c31e51-a62d-4b5e-87d4-7fa753d49e37/jth_4700_f1.gif)
The PAI‐1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women - SAID - 2012 - Journal of Thrombosis and Haemostasis - Wiley Online Library
![IJMS | Free Full-Text | PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea? IJMS | Free Full-Text | PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?](https://pub.mdpi-res.com/ijms/ijms-23-05516/article_deploy/html/images/ijms-23-05516-g001.png?1652610235)
IJMS | Free Full-Text | PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?
![Table 1 from Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. | Semantic Scholar Table 1 from Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b0cb807d21acc9183134159ecee72ce92a17a4f0/3-Table1-1.png)
Table 1 from Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. | Semantic Scholar
![Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/5a7b9cfd-4868-4c42-b1bd-dbb76253c54f/atvbaha.119.313775.fig07.jpg)
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology
![Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome](https://www.spandidos-publications.com/article_images/mmr/9/3/MMR-09-03-0894-g00.jpg)
Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome
![Prothrombotic mechanisms of tumor cells. PAI-1: plasminogen activator... | Download Scientific Diagram Prothrombotic mechanisms of tumor cells. PAI-1: plasminogen activator... | Download Scientific Diagram](https://www.researchgate.net/publication/5311118/figure/fig2/AS:667197017956373@1536083573807/Prothrombotic-mechanisms-of-tumor-cells-PAI-1-plasminogen-activator-inhibitor-1-PC.png)
Prothrombotic mechanisms of tumor cells. PAI-1: plasminogen activator... | Download Scientific Diagram
![Figure 1 from Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer. | Semantic Scholar Figure 1 from Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/178306ac1ecd8ebc92d44a7e6ce9d76ee082aa6b/3-Figure1-1.png)